Optimizing Cholesterol Management Improves the Benefits of Percutaneous Coronary Intervention

J Am Coll Cardiol. 2020 Sep 22;76(12):1451-1454. doi: 10.1016/j.jacc.2020.07.050.

¹ Cardiometabolics Unit, Zena and Michael A. Wiener Cardiovascular Institute, Marie-Joesee and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai Icahn School of Medicine, New York, New York. Electronic address: robert.rosenson@mssm.edu.
² Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama.
³ Michigan Nanotechnology Institute for Medical and Biological Sciences, Taubman Medical Research Institute, Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.

No abstract available

Keywords: LDL cholesterol; cardiovascular outcomes; guidelines; percutaneous coronary intervention; statin intolerance; statins.

Publication types